Sun Settles On Revlimid As Natco Scoops First ANDA Approval

Indian Firm Joins Number Of Companies To Settle

 
• By Dean Rudge

Sun Pharma has become the latest ANDA sponsor to settle litigation with Celgene over Revlimid, shortly after Natco and partner Teva picked up the first ANDA approval for the blockbuster treatment for multiple myeloma.

Businessmen_Rocket
Sun will eventually compete with Natco, which is eligible to launch first • Source: Shutterstock

More from Generics

More from Products